Discover 220 paid clinical trials in Sioux Falls, South Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 220
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
for
Malignant Neoplasm
Location: Sioux Falls SD, Fargo ND, Clermont FL
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07252739
Phase2, Recruiting
Active & Responsive
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Sioux Falls SD, Fargo ND, Springfield MO, Ann Arbor MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06305754
Phase3, Recruiting
Active & Responsive
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
for
Overactive Bladder (OAB)
Location: Sioux Falls SD, Omaha NE, Barrington IL,
Sponsor: FemPulse Corporation
Sex: Female
Age: 21+
Code: NCT07195656
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
for
Rare Disorders, Undiagnosed Disorders,
Location: Sioux Falls SD
Sponsor: Sanford Health
Sex: All
Age: 0+
Code: NCT01793168
Recruiting
Active & Responsive
Helix Research Network
for
Genetic Predisposition to Disease, Genetics Disease
Location: Sioux Falls SD, Omaha NE, Bloomington MN, Fort Wayne IN,
Sponsor: Helix, Inc
Sex: All
Age: 18+
Code: NCT06057181
Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: Sioux Falls SD, Maple Grove MN, Cincinnati OH,
Sponsor: Faeth Therapeutics
Sex: Female
Age: 18+
Code: NCT06463028
Phase2, Recruiting
Active & Responsive
Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™